Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,020 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection.
Nakano M, Kawaguchi T, Nakamoto S, Kawaguchi A, Kanda T, Imazeki F, Kuromatsu R, Sumie S, Satani M, Yamada S, Torimura T, Kakuma T, Yokosuka O, Sata M. Nakano M, et al. Among authors: kawaguchi t, kawaguchi a. Oncol Rep. 2013 Nov;30(5):2049-55. doi: 10.3892/or.2013.2700. Epub 2013 Aug 27. Oncol Rep. 2013. PMID: 23982634
Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy.
Niizeki T, Sumie S, Torimura T, Kurogi J, Kuromatsu R, Iwamoto H, Aino H, Nakano M, Kawaguchi A, Kakuma T, Sata M. Niizeki T, et al. Among authors: kawaguchi a. J Gastroenterol. 2012 Jun;47(6):686-95. doi: 10.1007/s00535-012-0555-6. Epub 2012 Mar 1. J Gastroenterol. 2012. PMID: 22382631 Clinical Trial.
Serum albumin level is a notable profiling factor for non-B, non-C hepatitis virus-related hepatocellular carcinoma: A data-mining analysis.
Yamada S, Kawaguchi A, Kawaguchi T, Fukushima N, Kuromatsu R, Sumie S, Takata A, Nakano M, Satani M, Tonan T, Fujimoto K, Shima H, Kakuma T, Torimura T, Charlton MR, Sata M. Yamada S, et al. Among authors: kawaguchi t, kawaguchi a. Hepatol Res. 2014 Aug;44(8):837-45. doi: 10.1111/hepr.12192. Epub 2013 Aug 4. Hepatol Res. 2014. PMID: 23819517
Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: A prospective study.
Sumie S, Kawaguchi T, Kawaguchi A, Kuromatsu R, Nakano M, Satani M, Yamada S, Okamura S, Yonezawa Y, Kakuma T, Torimura T, Sata M. Sumie S, et al. Among authors: kawaguchi t, kawaguchi a. Mol Clin Oncol. 2015 Jan;3(1):115-120. doi: 10.3892/mco.2014.435. Epub 2014 Oct 6. Mol Clin Oncol. 2015. PMID: 25469280 Free PMC article.
Prognostic profile of patients with non-viral hepatocellular carcinoma: A comparative study with hepatitis C virus-related hepatocellular carcinoma using data mining analysis.
Noda Y, Kawaguchi T, Kuromatsu R, Komukai S, Nakano M, Niizeki T, Koga H, Kawaguchi A, Torimura T. Noda Y, et al. Among authors: kawaguchi t, kawaguchi a. Oncol Lett. 2019 Jul;18(1):227-236. doi: 10.3892/ol.2019.10285. Epub 2019 Apr 25. Oncol Lett. 2019. PMID: 31289492 Free PMC article.
Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis.
Kawaguchi T, Shiraishi K, Ito T, Suzuki K, Koreeda C, Ohtake T, Iwasa M, Tokumoto Y, Endo R, Kawamura NH, Shiraki M, Habu D, Tsuruta S, Miwa Y, Kawaguchi A, Kakuma T, Sakai H, Kawada N, Hanai T, Takahashi S, Kato A, Onji M, Takei Y, Kohgo Y, Seki T, Tamano M, Katayama K, Mine T, Sata M, Moriwaki H, Suzuki K. Kawaguchi T, et al. Among authors: kawaguchi a. Clin Gastroenterol Hepatol. 2014 Jun;12(6):1012-8.e1. doi: 10.1016/j.cgh.2013.08.050. Epub 2013 Sep 10. Clin Gastroenterol Hepatol. 2014. PMID: 24036055
1,020 results